Jen Johnson: Hello hello. Thanks for making time to talk, I know you are both flat out
Peter Waples-Crowe:
Yeah its crazy! Anne and I have been working together doing the Deadly Sexy Health training, which is all online now of course. Its been really good.
Anne Roseman:
Yep! So busy, but Peter keeps me honest. We cover six different topics and we have a really broad range of people who are doing the training.
Peter:
So incase people don't know, the Deadly Sexy Health Kit is a health promotion resource which was created by VACCHO in conjunction with Aboriginal communities help with starting conversations and building skills with sexual health and BBVs in a culturally safe way. We recently had a bunch of Aboriginal youth workers from Dandenong, who can now do more BBV and STI support and prevention work with the Aboriginal young people they work with, which is so great.
Jen: So how’s it all going for you both, in this year of COVID?
Peter:
Oh there have been so many big changes. As an Aboriginal person VAHS (the Victorian Aboriginal Health Service) has been a hugely important place for me, and for lots of Aboriginal people. It has always been this place where we can all go and can meet up and connect with community. So not being able to go down to VAHS has been hard.
But the Aboriginal community in Victoria has done really well, we have supported each other well, and really looked after our elders. Community is really making the most of social media, for example there is a really active COVID Facebook group which is all about supporting elders and looking after each other. A real grassroots movement to look after our own. This is the way our community works. And that’s exactly what community control is all about: Aboriginal health in Aboriginal hands. There have been cases of COVID-19 in Aboriginal communities but not that many. No as many as everyone thought earlier this year. We have done really well as a community to keep the numbers low and support each other.
Anne:
COVID, and the amazing way that Aboriginal communities have handled COVID, has shown the way for so many people to understand Aboriginal community control. For a long time we’ve had motherhood statements about self-determination, but this year we have seen how it works, how communities switch into action. COVID is an example of community action, how communities lead the way, how they band together and support each other.
If you look at the national COVID 19 response for Aboriginal and Torres Strait Islander communities, those in the BBV/STI sector have led the response. For example we saw really quickly the repurposing of rapid STI testing machines to be used for COVID testing, and then these were made available to go into communities.
But of course this didn’t just happen, much of it is the result of decades of tireless work by the incredible BBV/STI champion James Ward. He is an Aboriginal man, a researcher, and he works closely with Aboriginal Peaks, NACCHO and strategically with governments. Basically, if you look at any community-involved Aboriginal research project in BBV/STI, James Ward has been involved. He led the ATLAS Sentinel Surveillance Project , Young, Deadly Free , and the Goanna study to name a few. And the key to his success is that he keeps community control first and foremost, that’s how he makes it work. He was the first researcher to include the ACCO sector at a national level with multiple BBV/STI research projects, and he has done so much to develop the capacity of Aboriginal-led research in the development of young researchers.
Jen: So do you think the way that communities and community-controlled health has been so successful in protecting Aboriginal communities from COVID could be used at this point to advocate for greater investment in community-controlled Aboriginal BBVSTI programs?
Anne:
Absolutely. Sexual health and BBVs are trickier in some respects than COVID. A huge part of the work we do is acknowledging trauma, and intergenerational abuse, and sexual health work is a direct line to a lot of that trauma. Whether its reproductive health and fertility, sexual assault, the removal of children, and all the ways that trauma gets wrapped up in alcohol and drug use. Trauma also slows the pace of the work, and we must tread lightly. Look at the latest Victorian DHHS hepatitis C stats, in 2019 the rate of new hepatitis C infections was 28 times higher among Aboriginal people than non-Aboriginal people. That’s it, that is trauma in action.
Peter:
And as Aboriginal health workers, we are part of the community and we are also traumatised. Its one thing to look at the effects of colonisation, but we need to see that trauma is real and it impacts everything. I now work at Thorne Harbour Health, which is a mainstream service. My work is informed by my partnerships with VACCHO and the ACCHO sector. Not long ago I worked at VACCHO, in Anne’s job. And like so many people who work in and also belong to communities that experience trauma, I just got to the point where I couldn’t expose myself to more trauma, I couldn’t listen any more. I had my own issues. I’m often asked to speak on behalf of the community, but I can’t, I can only speak for myself.
It’s so different working in a mainstream service, in the only dedicated Aboriginal health position. It’s a great start, but there are so many bigger systemic issues in mainstream organisations that its going to take time to change the culture.
Anne:
Lots of people approach ACCOS with good ideas for collaborative projects or research studies, but they have limited contact with Aboriginal people, so it’s hard to check with communities first. This means that many mainstream services don’t know how to engage or have little time or funding to spend time to build trust with ACCOs . ACCO’s themselves have little time to do the development work as they are chronically underfunded and so busy trying to meet the needs of their communities. This can be frustrating for all. To be invested in real outcomes, we need to support self-determination and to advocate and for systematic change. It would be so much more efficient to invest in the community-controlled sector, to allocate funding directly to ACCOs to lead this work. ACCO’s have intimate knowledge of their own communities, and how to deliver services to them. Research and projects should also be Aboriginal-led, community led, and funded appropriately. We need to invest in building capacity for research in the Aboriginal community-controlled sector.
Peter:
That’s so true, and that’s why James Ward stands out. Goanna, the first ever survey of STI and BBVs knowledge and practice among young Aboriginal and Torres Strait Islander people, was run by community-controlled organisations around the country. The survey found that there are a lot more young Aboriginal and Torres Strait Islander people in the LGBTIQ+ spectrum than we really knew, and it also showed that the proportion of our young people with LGBTIQ+ experiences and identities is the same as in the general population. And we also found out that young queer and gender diverse Aboriginal people want to go to ACCHOs for support, advice and health care. This was a really important finding, and because of this increased knowledge, many of the Victorian ACCHOs are already on, or thinking of going on the journey of becoming more LGBTIQ inclusive. This has really fuelled a lot of my work at Thorne Harbour Health in the last year as we need to create safe spaces and provide service options for Aboriginal LGBTIQ people.
We need to invest in the BBVSTI workforce, but a big part of that is building up with Aboriginal harm reduction peer workforce. In sexual health and HIV prevention we have lots of lived experience in the queer community. But the rates of hep C in Aboriginal communities are too high, and we need to talk about it more. But its still hard in our community, its hard to talk about because of how it connects us to trauma. And its hard to find young people who want to step into working in BBV. But that’s what we need to address hepatitis C, we need to work toward a peer workforce.
Jen: The Aboriginal BBVSTI workforce is spread so thin.
Anne:
In ACCO’s we have 1 EFT for BBVSTI programs for the whole of Victoria. It’s just not enough. We need skin in the game, we need a bigger workforce. We need proper ongoing community consultation and projects that are funded beyond 12 months. Aboriginal communities are invested in real outcomes and are working in the deep end. But we need to get beyond just investing in the shallow end.
Want to learn more about Aboriginal community control? Check out this new resource .
New Positive Women Podcast: Our stories: ending HIV stigma
Positive Women Victoria are excited to announce the launch of their brand new podcast, Our Stories: Ending HIV Stigma. This is a podcast about women by women living with HIV in Australia that challenges the myths and stereotypes that feed HIV stigma.
The series is a one-on-one conversation with women living with HIV, where amazing women share stories about their life goals, navigating sex and relationships, pregnancy and motherhood. They discuss what it means to be confident in this new era of U=U (Undetectable = Untransmittable), and what this means for them.
The stories of three dynamic women are available now to listen:
- Charlotte shares her story of how, when as a young woman on a trip to Bali, life suddenly spiralled out of control. Later diagnosed with HIV, Charlotte overcame addiction, and now has three beautiful children, all born free of HIV.
- Brittney contracted HIV during surgery as a child and is now a mum herself. She tells how HIV never held her back.
- Batsirai begins her story in Africa, and continues in Australia. This revealing story highlights the importance of public discussion of HIV to encourage awareness, testing, and challenge the myths that underpin stigma.
Listen via Positive Women Victoria or at Spotify , Apple , Google or wherever you download your podcasts.
New research: hepatitis C-related discrimination in a post-cure world
At present the cure for hepatitis C is often posed as able to radically transform people’s lives and lead to a revolutionary ‘new’, ‘future’ life, where people who once had hepatitis C or use drugs are no longer denigrated. These hopes are subject to undermining by persistent stigma and discrimination.
A major new project now launching at ARCSHS aims to explore these issues, focussing on post-cure lives. The project aims to identify and analyse the forces that adversely impact on post-cure lives, and develop practical strategies and reforms to reduce post-cure stigma and discrimination.
25 years of measuring the health of marginalised, resilient communities who inject drugs
The latest report by The Australian Needle Syringe Program (NSP) Survey marks 25 years of significant research conducted in partnership with a marginalised community, and reveals the key trends of the last decades.
The NSP Survey monitors HIV, hepatitis C and sexual and drug use behaviours among people who inject drugs and is one of the longest running surveys of its kind internationally. It is led by Professor Lisa Maher at the Kirby Institute at UNSW Sydney.
The report shows that over the past 25 years, HIV prevalence has remained remarkably low (less than 3%). Although hepatitis C prevalence has been historically high, prevalence has significantly declined in recent years.
New resources from Hepatitis Australia:
1. Hepatitis B Guide and Infographic Video
The Hepatitis B Guide explains the process from being tested for hepatitis B to living well with chronic (life-long) hep B. The Hepatitis B Infographic Video supplements the Hepatitis B Guide, providing an alternative format to make the information more accessible.
Go to Hepatitis B Guide and infographic video
2. If tatts could talk
This new series of animated videos targets individuals who may consider getting tattoos done outside of a professional tattoo or piercing studio in Australia. In a tattoo studio based in Australia, your chances of getting hepatitis B or hepatitis C are almost nil as our professional body artists follow very strict regulations. Go to If tatts could talk
3. Hepatitis B Liver Monitoring Video
This creative new video was developed in consultation with people living with hepatitis B and reflects some of their experiences with the disease. The creative went through a process of community consultation that involved interviews with individuals from priority populations. Go to Hepatitis B Live Monitoring Video . This video has also been narrated in several languages including Cantonese , Mandarin , Khmer and Vietnamese
4. Hepatitis C Guides and Infographic Video
These GP and Patient guides show the pathway from testing for hepatitis C to getting cured. They are designed to help people living with or at risk of hepatitis C seek treatment and to inform discussions with their doctors.
The Hepatitis C Infographic Video supplements the hepatitis C guides, providing an alternative format to make the information more accessible. Go to Hepatitis C Guides and Infographic video
5. Your Rights and Responsibilities
In Australia, people living with hepatitis B and hepatitis C have rights that protect them from being discriminated against and certain responsibilities to protect public health.
This guide provides information about the legal rights and responsibilities of people living with hepatitis B or C. Go to Your Rights and Responsibilities
Report on the PrEP in NSW Transition Study, 2018–2020
Over the period August 2018 to March 2020, 2,344 people who had been offered HIV pre-exposure prophylaxis (PrEP) as part of the Expanded PrEP Implementation in Communities New South Wales (EPIC-NSW) trial agreed to be followed-up for a further 12 months as part of the PrEP in NSW Transition Study. This was to help us understand how people transitioned out of a PrEP implementation trial to receiving PrEP through general practice and standard-of-care prescribing, and any associated changes in behaviour, attitudes or engagement with sexual health. Download the report from the PrEP in NSW Transition Study.
The INTO? Study: Report of Results
The INTO? study was a cross-sectional survey of gay and bisexual men (GBM) in Australia conducted between December 2019 and March 2020. INTO? examined recent sexual and drug use events, with a focus on how biomedical HIV prevention methods may affect the negotiation of sex and drug use practices. Focusing on specific events rather than behaviour over a period of time can be useful to understand the complexities and specifics of intentions, behaviours, and disclosure of HIV status as individuals negotiate sex with different partners. Download the report form the INTO? Study .
2020 CSRH Annual Report of Trends in Behaviour (ARTB)
The Annual Report of Trends in Behaviour (ARTB) presents data from a selection of the behavioural and social research conducted by the Centre for Social Research in Health. The report focuses in particular on studies assessing trends over time or addressing emerging issues.
The 2020 data is presented in two reports, one focusing on viral hepatitis and the other on HIV and STIs .
Researching peer-led responses — Reflections on 20 years of collaboration, advocacy, and creating change
Associate Professor Graham Brown’s reflections on what he has experienced and learnt from two decades of collaborations and relationships with peer-led organisations. Click here for a blog post, and an onward link to Graham’s recent ARCSHS seminar. We miss you Graham!
Moving beyond people-first language: a glossary of contested terms in substance use
The drugs field deploys a huge range of technical terms and jargon. Much of this is borrowed from other fields – medicine, research, statistics, sociology etc. There are also terms used by people who use drugs and terms specific to treatment and recovery contexts. Some of the language used is contentious or misunderstood. This resource allows people to understand contested terms and understand how language can result from and perpetuate stigma.
This article ( The Power of Words ) also explores the importance of understanding and avoiding stigmatising language in pharmacy settings.
Two new posters for LBGBTIQ First Nations people
THH are proud to release two posters developed in partnership with Elizabeth Morgan House and the Zoe Belle Gender Collective celebrating our LGBTI and queer First Nations communities. These posters support the work of the Aboriginal and Torres Strait Islander health project at THH, which focuses on health promotion, cultural safety, LGBTI inclusion and HIV support. https://thorneharbour.org/lgbti-health/aboriginal-and-torres-strait-islander-health/
EASL 2020 Virtual Conference: Rapid Audio Recap
In this episode, Dr. Stefan Zeuzem discusses results from key viral hepatitis studies reported at the 2020 Digital International Liver Congress, organized by the European Association for the Study of the Liver, including important findings from the following reports:
- Update on global progress toward HCV elimination goals
- SToP-C: HCV treatment-as-prevention in Australian prisons
- SHARED cohort: correlates of treatment failure with GLE/PIB or SOF/VEL/VOX
- Trio Health: retreating HCV with GLE/PIB or SOF/VEL/VOX after DAA failure
- Stop-NUC: discontinuation of long-term nucleos(t)ide analogue therapy in patients with HBeAg-negative chronic HBV infection
- High-dose bulevirtide for chronic HBV/HDV coinfection
- Summary of select agents under early-phase investigation for HBV treatment
Access the recording here
VALE Timothy Ray Brown
Timothy Ray Brown, the First Person Known To Be Cured of HIV, Has Died of Cancer at 54
Articles written by Timothy Ray Brown
I Am the Berlin Patient: A Personal Reflection
Timothy Ray Brown's Continuing Activism Toward Curing HIV
Don't Let Funding Caps to NIH Researchers Harm Highly Collaborative HIV Cure Research
The London Patient
Federal budget 2020 response
The Australian Injecting and Illicit Drug Users League (AIVL) has expressed disappointment there is little evidence of new investment in the alcohol and other drugs (AOD), blood borne virus (BBV) and sexually transmissible infection (STI) sectors to address additional demand and challenges for service delivery associated with COVID-19.
Hepatitis Australia welcomes the Australian Government’s commitment to diverse hepatitis research, with the 2020 Health Budget describing funding for pathogen genomics, prison-based interventions, and point-of-care testing. However they remain concerned that the 2019 Health Budget funding for hepatitis commitments is yet to hit the ground.
Victorian cancer plan 2020–2024 Improving cancer outcomes for all Victorians
Hepatitis B and C are included as priority areas in the new Victorian cancer plan , reflecting the urgent need to reduce the incidence of liver cancer in Victoria.
'Till death do us part': the HIV-positive couple helping thousands with the same illness
Nobel Prize for Medicine goes to Hepatitis C discovery
Past webinars
Stigma among people who inject drugs and people living with hepatitis C
Loren Brener and Tim Broady discuss stigma among people who inject drugs and people living with hepatitis C with Jude Byrne and Jenny Heslop. View recording
Upcoming events
Why trust digital health? Understanding the perspectives of communities affected by BBVs/STIs and social stigma – 21 October
4:00pm – 5:00pm
The use of integrated digital health systems has the potential to improve health and wellbeing but some of the communities who could benefit most from these systems also have the best reasons for not trusting them. Communities affected by blood borne viruses (BBVs) and sexually transmitted infections (STIs) can experience stigma and discrimination from health care professionals and face serious risks to their capacity to work and parent if information on criminalised practices is shared. Yet little social research has explored the views and practices of these communities about storing and sharing personal data in digital health systems and technologies.
In this seminar, James MacGibbon, Anthony KJ Smith and Christy Newman discuss key findings from a national community survey and key informant interviews conducted in the Trust in Digital Health study : a partnership between the UNSW Centre for Social Research in Health and community organisations representing people with HIV, sex workers, gay and bisexual men, and trans and gender diverse people in Australia. Register here
HEPReady Essentials Online Course - 27 October
9:30am - 12:00pm
The HEPReady® Essentials course is designed for health and community workers who want a comprehensive overview of viral hepatitis and liver health. This two hour and a half hour session features a powerful account of a lived experience speaker. It will also help you gain valuable insight into privacy and disclosure requirements associated with viral hepatitis.
It also covers
- Functions of the liver
- Viral hepatitis and disease progression
- Hepatitis A, B and C : prevalence, transmission, risky behaviour, testing and treatment
- A lived experience speaker
- Stigma and discrimination
- Case studies: conducting sensitive conversations with clients
This course also includes access to an online learning portal that is equipped with exclusive Essentials educational resources that you can cover at your own pace. All attendees will receive a certificate, endorsed by the Australian Primary Healthcare Nurses Association (APNA).
Cost = $60 (including GST) REGISTER NOW
Invoices will be emailed to businesses/individuals. For more information about HEPReady Essentials visit the Hepatitis Victoria website , email pearl@hepvic.org.au or call (03) 9380 4644.
Navigating Hepatitis C Care Webinars – 10 November and 18 November
Hepatitis C can be cured in 98% of people by taking medication with few side effects for 8-12 weeks. We need to increase access to these lifesaving medications as testing and treatment rates are falling in Australia.
These interactive education sessions explore hepatitis C when it presents alongside other health issues that can present major challenges to accessing care. The aims are to:
- Understand the importance of considering hepatitis C within the social context of people’s lives
- Increase awareness of co-morbidities
- Explore strategies to engage and support clients into health care.
Session 1 - Navigating Hepatitis C and Homelessness
- Karyn Gellie, Registered Nurse, Team Co-ordinator at Bolton Clarke Homeless Persons Program
- Gabrielle Bennett, CNC/Victorian Viral Hepatitis Educator, St Vincent’s Melbourne.
Tuesday 10 November, 10am - 11am, Click here to register
Session 2 - Navigating Hepatitis C and Mental Illness
- Barb Williams - Credentialed mental health nurse with post grad qualifications in AOD nursing. Barb currently works at the Medically Supervised Injecting Room as a Senior Mental Health Clinician with St. Vincent’s Melbourne.
- Gabrielle Bennett, CNC/Victorian Viral Hepatitis Educator, St Vincent’s Melbourne.
Wednesday 18 November, 10am - 11am Click here to register
Suitable for health workers who work in AOD, NSPs, mental health, community health, nurses, or anyone who works with people who are at risk of or affected by Hepatitis C. Nurses earn 1 CPD point.
27th National Hepatitis Symposium webinar series – 17 November, 1 December and 8 December
Due to the current restrictions on meetings and interstate travel, this year St Vincent's Hospital Melbourne will be hosting the event as a free three-part webinar series. The Symposium will include local and international presenters who will provide an important update on the treatment and management of patients with viral hepatitis, fatty liver disease and hepatocellular carcinoma.
Speakers
- Professor John Dillon, Ninewells Hospital, Dundee/ University of Dundee, Scotland
- Associate Professor Leon Adams, Sir Charles Gairdner Hospital, Perth
- Associate Professor Joe Doyle, Burnet Institute/Alfred Hospital, Melbourne
- Dr Thomas Tu, Westmead Institute for Medical Research, Sydney
The three webinars are:
- Hepatitis C : Remaining Challenges - Tuesday17 November, 7pm – 8.30pm
- HBV & HCC : Changing Landscapes - Tuesday 8 December, 7pm – 9.pm
- Fatty Liver Disease : The ‘other’ hepatitis - Tuesday 1 December, 7pm – 8.30pm
Registering for any of the meetings will give you immediate access to all meetings in the series.
Click here to register
Hep B made easy – A CEH & St Vincent’s Hospital Webinar – 19 November, 12pm – 1pm
More than 200,000 people in Australia are living with hepatitis B. Because the infection often has no symptoms until serious liver disease develops, only about 60% of people who are living with the virus are aware that they have been infected with hepatitis B. If left untreated, it can lead to cirrhosis, liver failure and liver cancer. The disease can be successfully managed if treated early. The majority of people living with hepatitis B in Australia come from culturally and linguistically diverse communities.
CEH’s Hep B made easy workshop will help you:
- understand the basic facts about hepatitis B testing, diagnosis, transmission & treatment
- explore strategies that meet the needs of affected communities
- gain knowledge on how to deliver appropriate health literate and culturally competent care to people affected by hepatitis B
- learn about resources, supports and websites that assist health workers and the affected communities to seek help.
Registration here
Joint HIV&AIDS and Sexual Health Conferences: VIRTUAL
16 - 20 November 2020
Start planning your attendance at this year's virtual conference. The program overview is now available to view on the conference website .
The Joint Virtual Program will comprise of topical interactive live sessions, live Q & A, live polling, plenaries, and On Demand content as well as the opportunity to connect with each other via the Meeting Hub.
Call for participants: Migrant Blood-borne Virus and Sexual Health Survey
MiBSS stands for Migrant Blood-borne Virus and Sexual Health Survey . It is a study led by Curtin University (Western Australia) in partnership with universities and community organisations in Victoria, South Australia, Queensland and New South Wales. The aim of the study is to develop a greater understanding of how migrants living in Australia think and act on the subjects of sexually transmitted infections (STIs) and blood-borne viruses (BBVs).
BBVs and STIs affect all groups of people living in Australia. However, we currently don't have much information about the knowledge, attitudes, behaviours or practices of migrant populations living in Australia. By finding out more information, we will be able to understand whether Australian health services are meeting the needs of over-seas born communities and what improvements can be made.
We are asking people to complete a survey if they were born in Sub-Saharan Africa, South-East Asia and North-East Asia who are living in Western Australia, South Australia, New South Wales, Victoria or Queensland. The survey is anonymous meaning there is no way of identifying individual respondents. The survey is available online at this link .
Upcoming Events at Living Positive Victoria – relationships workshop, Christmas party (and toy drive), and AGM
1. On 31 October, 2pm - 4pm we will be hosting a Zoom workshop on talking about HIV+ relationships. This event is for womxn, heterosexual men and their partners: https://livingpositivevictoria.org.au/event/talking-hiv-positive-relationships/
2. On 20 December, 4pm - 5pm will be our annual family Christmas party. Sadly we cannot host it in person but have managed to book Santa for a hour of fun for the kids. This event is for womxn, heterosexual men, their partners and immediate families, details here . We will be providing toys for all the kids that attended up to the age of 15yo but we need your help to make sure no one misses out, so we have launched our annual toy drive. To buy some Christmas Cheer this year please click here, all donations are greatly appreciated.
3. Finally Living Positive Victoria’s AGM will be hosted 22 October, 6pm-- 7pm, for more information on how you can help shape the future of HIV in Victoria please follow this link .
Sex workers
Scarlet Alliance - Status of Return to Work and Changing of Restrictions
Each state and territory government alongside the National Cabinet, has started a process to ease the restrictions that were put in place to help slow the spread of coronavirus (COVID-19). Some states and territories have not yet announced return to work dates for sex service premises. Others have already returned to work or have dates in place. Details of restrictions in each state and territory, current as of 24/9, can be found here http://www.scarletalliance.org.au/library/return_to_work_Sept2020/
Victoria’s opportunity to decriminalise sex work
UNSW academics argue that the review into sex work could result in positive changes to the working conditions for many sex workers.
As the Victorian Government conducts its review into the regulation of sex work, the push for decriminalisation is accelerating across the country. With the recent vote to decriminalise sex work in the Northern Territory and with it being twenty-five years since NSW partially decriminalised, Victoria is now in a unique position to improve the health, rights and safety of sex workers in the state. Headed by Member for Northern Metropolitan Region Fiona Patten, the six-month inquiry is the first large-scale review of sex work legislation in Victoria since 1985. Read the article.
LGBTIQ communities
In the latest Thorne Harbour CEO Update, Simon Ruth talks about changes. He speaks about the changes we're starting to see as a result of our collective response to COVID-19. He also speaks about the exciting change for Thorne Harbour as we prepare to move into 200 Hoddle Street and the Victorian Pride Centre. WATCH
Coronavirus lockdown: LGBTQ people face hostility and loneliness
People living with HIV
European AIDS Treatment Group documents the impact of COVID on HIV services throughout Europe
People living with viral hepatitis
International registries provide more information about COVID-19 and liver disease
People who use drugs
'A miracle if anyone got clean': Australia's drug users fight for treatment during pandemic
COVID changed the way we use drugs and alcohol — now it’s time to properly invest in treatment
ARCSHS – Research Officer
The Research Officer will support the interdisciplinary ARC Discovery project ‘Addressing hepatitis C-related discrimination in a post-cure world’ (DP200100941) led by Associate Professor Kate Seear. The appointee will undertake some of the research tasks associated with the study and will assist in supervision of more junior staff with key tasks. They will be appointed to manage day-to-day aspects of the project and conduct higher-level duties such as coordination of sector relationships, coordination of the project advisory board, ethics application preparation, and assist in recruitment, interviewing and coding interviews. They will also undertake some routine tasks such as interview checking and cleaning. Applications close 3 November, all details can be found here .
Disparities in characteristics in accessing public Australian sexual health services between Medicare‐eligible and Medicare‐ineligible men who have sex with men
Hepatitis C and HIV combined screening in primary care: A cluster randomized trial
Association between viral hepatitis infection and Parkinson's disease: A population‐based prospective study
Substantial decline in use of HIV pre-exposure prophylaxis (PrEP) following introduction of COVID-19 physical distancing restrictions in Australia. Results from a prospective observational study of gay and bisexual men. (+ summary article here )
HIV stigma by association among Australian gay and bisexual men
Early impact of COVID-19 social distancing measures on reported sexual behaviour of HIV pre-exposure prophylaxis users in Wales
Psychological wellbeing facilitates accurate HIV risk appraisal in gay and bisexual men
Risk of birth defects and perinatal outcomes in HIV-infected women exposed to integrase strand inhibitors during pregnancy
Is Patient Navigation Used by People with HIV Who Need It? An Assessment from the Medical Monitoring Project, 2015 − 2017
Developing a patient-reported outcome measure for HIV
Two-thirds of people living with HIV would like to try injectable treatment, according to European survey
Weight gain on HIV treatment: what is normal, and what is harmful?
Promising results for programme to reduce sleep disturbance in people with HIV
Long-acting injectables work without oral lead-in period
Risk of smoking-related cancers among women and men living with and without HIV
Asymptomatic HIV-associated neurocognitive impairment increases risk for symptomatic decline
Effect of Truvada lawsuit advertising on preexposure prophylaxis attitudes and decisions among sexual and gender minority youth and young adults at risk for HIV
Ending an HIV epidemic among persons who inject drugs (PWID) in a middle-income country - extremely low HIV incidence among PWID in Hai Phong, Viet Nam
A systematic review of early adoption of implementation science for HIV prevention or treatment in the United States
Decision-making regarding condom use among daily and event-driven users of pre-exposure prophylaxis in the Netherlands – a mixed-methods analysis
Delivering PrEP to adults with “low” or “no” HIV risk and youth: experiences and perspectives of PrEP providers
Housing Subsidies and Housing Stability are Associated with Better HIV Medical Outcomes Among Persons Who Experienced Homelessness and Live with HIV and Mental Illness or Substance Use Disorder
Coverage of Sex Acts by Event-Driven Pre-exposure Prophylaxis: A Sub-Study of the ANRS IPERGAY Trial
Pre-exposure Prophylaxis (PrEP) for HIV Prevention Among Men Who Have Sex with Men (MSM): A Scoping Review on PrEP Service Delivery and Programming
Broaching the Topic of HIV Self-testing with Potential Sexual Partners Among Men and Transgender Women Who Have Sex with Men in New York and Puerto Rico
Facilitating hepatitis B clinical management in general practice A qualitative investigation
Impact of a nurse‐led enhanced monitoring, management and contact tracing intervention for chronic hepatitis B in England, 2015‐2017
EASL conference: Experimental treatments for hepatitis B
Update on epidemiology of hepatitis B in a low‐endemic European country: There is still much to do
Low risk of hepatitis B reactivation in patients with severe COVID‐19 who receive immunosuppressive therapy
Applying a diffusion of innovations framework to the scale-up of direct-acting antiviral therapies for hepatitis C virus infection: Identified challenges for widespread implementation
The case for simplifying and using absolute targets for viral hepatitis elimination goals
Screening Emergency Admissions at Risk of Chronic Hepatitis C (SEARCH) to diagnose or ‘re‐diagnose’ infections is effective in Australia
Loss to follow‐up in the hepatitis C care cascade: A substantial problem but opportunity for micro‐elimination
SARS-CoV-2 massive testing: a window of opportunity to catch up with HCV elimination
Models can help predict liver cancer in people cured of hepatitis C
The role of social capital in facilitating hepatitis C treatment scale‐up within a treatment‐as‐prevention trial in the male prison setting
Determinants of stigma among patients with hepatitis C virus infection
Impact Of Direct Acting Antiviral Agents On Liver Function In Patients With Chronic Hepatitis C Virus Infection
Detection of Recurrent Hepatitis C Viremia Using Surveillance Data, New York City
Micro-elimination of hepatitis C among people with HIV coinfection: declining incidence and prevalence accompanying a multi-center treatment scale-up trial
Life after hepatitis C cure in HIV‐infected people who inject drugs and men who have sex with men treated with direct‐acting antivirals in France: Health perceptions and experiences from qualitative and quantitative findings
Hepatitis B Surface Antibody Titers and Hepatitis B Reactivation with Direct‐Acting Antiviral Therapy for Hepatitis C
Fatty liver disease common in people living with HIV and hepatitis B
HaRePo (harm reduction by post): an innovative and effective harm reduction programme for people who use drugs using email, telephone, and post service
‘Peer’ work as precarious: A qualitative study of work conditions and experiences of people who use drugs engaged in harm reduction work
Assisted injection within supervised injection services: Uptake and client characteristics among people who require help injecting in a Canadian setting
Distance matters: The association of proximity to syringe services programs with sharing of syringes and injecting equipment - 17 U.S. cities, 2015
Drug‐related harm coinciding with income assistance payments: results from a community‐based cohort of people who use drugs
Working with Aboriginal young people in sexual health research: a peer research methodology in remote Australia
Forward to a Friend
|